ArticleThe Journal of molecular diagnostics : JMD2010

Development of a diagnostic microarray assay to assess the risk of recurrence of prostate cancer based on PITX2 DNA methylation.

Philipp Schatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.